Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters.Vaccitech (Nasdaq: VACC) announced its initial public offering in…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now